Delivery Order SPE2DB20D3103-SPE2DB25FL3J0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,632.85 delivery order contract is for the supply of hydroxychloroquine 200 mg tablets. The contract has a firm fixed price and a completion date of March 22, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order valued at $3,741.38 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,557,125,734 units of Hydroxychloroquine 200mg tablets in 100-count bottles. The contract has an ultimate completion date of May 6, 2022 and was awarded on May 5, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,937.72 Firm Fixed Price delivery order is for the supply of 4,561,867 units of Hydroxychloroquine 200 mg tablets, with a completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,464 tablets of Hydroxychloroquine 200 mg. The $2,909.44 firm fixed-price contract has a completion date of September 15, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB23FL9X2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,778.42 firm fixed-price delivery order is for the supply of 4,559,444,350 units of hydroxychloroquine 200 mg tablets. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp...
- This federal contract award, with an ID of SPE2DB20D3104|SPE2DB22FV6T9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,829.34 firm fixed-price delivery order is for the supply of 4,557,140 units of hydroxychloroquine 200mg tablets. The contract has an ultimate completion date of May 9, 2022 and was awarded on May 6, 2022. This award is not designated as a set-aside contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Hydroxychloroquine 200 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,408.15. The award date was March 28, 2022, with an ultimate completion date of March 29, 2022. The contract does not have a set-aside designation, indicating open competition....
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,932,255 tablets of Hydroxychloroquine 200 mg, a critical pharmaceutical product. The Firm Fixed Price contract has a ceiling value of $8,276.28 and a completion date of July 29, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of hydroxychloroquine 200 mg tablets in 100-count bottles, with a ceiling value of $3,909.46 and a completion date of September 3, 2024. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...
- This federal contract award is for the delivery of hydroxychloroquine 200 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a parent company called Cencora, Inc. The contract has a ceiling value of $3,652.07 and was awarded on September 13, 2021, with a completion date of September 14, 2021. It is a firm fixed-price delivery order contract, with no set-aside designation....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FL3J0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,727.92 firm fixed-price delivery order is for the supply of 4,566,077,675 units of hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of October 11, 2024. This award is a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/10/24 |